NEW YORK, July 31 - Intrinsic Bioprobes, of Tempe, Ariz., has won a patent in the United States for its "bioactive chip" technology, the company said today.
US patent No. 6,569,383 covers the use of a single bioactive chip to prepare samples for high-throughput protein analysis, "particularly through advantageous techniques of analyte isolation, modification, and concentration," Intrinsic said.